The State Street Health Care Select Sector SPDR ETF (XLV) reported a notable week-over-week outflow of approximately $467.1 million, resulting in a 1.2% decrease in shares outstanding, from 259,915,324 to 256,915,324. This outflow occurred amid mixed performance for key constituent companies, with Abbott Laboratories (ABT) trading flat, Amgen Inc (AMGN) down 0.2%, and Gilead Sciences Inc (GILD) lower by 0.3%.
Currently, XLV’s trading price is $155.36, within its 52-week range of $127.35 to $158.95. This reflects a significant deviation from its 200-day moving average, which could be relevant for technical analysis assessments.
